The state of Washington currently has 13 active clinical trials seeking participants for Migraine research studies. These trials are conducted in various cities, including Seattle, Spokane, Tacoma and Bellevue.
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Recruiting
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
Gender:
ALL
Ages:
Between 12 years and 17 years
Trial Updated:
12/09/2024
Locations: Mary Bridge Children's Hospital, Tacoma, Washington
Conditions: Chronic Migraine in Children